KZA 1.72% 59.0¢ kazia therapeutics limited

Novogen AFR article

  1. 3,567 Posts.
    Novogen

    advertisement

    advertisement

    Shares in the pharmaceutical developer continued to gain on Thursday, taking the stock's total gains to 65 per cent over the last 2 weeks. It was assisted on Tuesday when Novogen announced a lower than expected loss of $14.7 million. By early afternoon Novogen had risen 20¢, or 10 per cent, to $2.02, gaining momentum from a positive company report to shareholders outlining the development progress of its family of anti-cancer drugs with US company Marshall Edwards. Novogen said its Phenoxodiol ant-cancer drug had completed Phase 1 clinical trial successfully and was moving into Phase 2.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist
(20min delay)
Last
59.0¢
Change
0.010(1.72%)
Mkt cap ! $42.57M
Open High Low Value Volume
58.0¢ 60.0¢ 56.5¢ $130.7K 223.3K

Buyers (Bids)

No. Vol. Price($)
2 46044 56.5¢
 

Sellers (Offers)

Price($) Vol. No.
61.5¢ 5000 1
View Market Depth
Last trade - 15.04pm 28/02/2020 (20 minute delay) ?
(live)
Last
58.5¢
  Change
0.010 ( 0.86 %)
Open High Low Volume
58.0¢ 59.5¢ 57.0¢ 30150
Last updated 15.03pm 28/02/2020 (live) ?
KZA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.